Blog Posts Highlight Research Into New Drugs For Malaria, Other Diseases

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: a promising antimalarial and leishmaniasis vaccine, diagnostics for tuberculosis, and more
Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including the development of an experimental antimalarial drug and a potential leishmaniasis vaccine, clinical trials for new tuberculosis diagnostic tests, and research into pediatric-appropriate medicine dosages (6/22).

Humanosphere: New anti-malaria compound packs a big punch
Humanosphere reporter Tom Murphy discusses research on an experimental one-dose treatment for malaria that “can both kill the parasite and prevent [the disease] from spreading…” (6/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.